We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$390B
AUM Growth
+$20.4B
Cap. Flow
-$150M
Cap. Flow %
-0.04%
Top 10 Hldgs %
19.29%
Holding
4,064
New
197
Increased
1,617
Reduced
1,938
Closed
141

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$671M
2
NKE icon
Nike
NKE
+$557M
3
MCHP icon
Microchip Technology
MCHP
+$544M
4
V icon
Visa
V
+$535M
5
BDX icon
Becton Dickinson
BDX
+$487M

Sector Composition

Rank Sector Weight
1 Technology 24.06%
2 Financials 10.52%
3 Healthcare 9.63%
4 Industrials 8.45%
5 Consumer Discretionary 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFGL icon
3201
iShares International Developed Real Estate ETF
IFGL
$83.3M
$889K ﹤0.01%
38,951
+414
+1% +$8.9K
VREX icon
3202
Varex Imaging
VREX
$502M
$889K ﹤0.01%
74,565
-43,568
-37% -$555K
PLTK icon
3203
Playtika
PLTK
$1.54B
$884K ﹤0.01%
111,667
+3,174
+3% +$23.8K
RMTI icon
3204
Rockwell Medical
RMTI
$28.5M
$883K ﹤0.01%
+22,234
New +$598K
PSCM icon
3205
Invesco S&P SmallCap Materials ETF
PSCM
$21.1M
$878K ﹤0.01%
+10,930
New +$844K
SFIX
3206
Stitch Fix
SFIX
$552M
$878K ﹤0.01%
+311,208
New +$1.21M
FATE icon
3207
Fate Therapeutics
FATE
$291M
$874K ﹤0.01%
249,742
+7,310
+3% +$28.4K
TAL icon
3208
TAL Education Group
TAL
$6.7B
$868K ﹤0.01%
73,322
-8,192
-10% -$75.4K
NVRO
3209
DELISTED
NEVRO CORP.
NVRO
$866K ﹤0.01%
+154,976
New +$1.08M
CNSL
3210
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$864K ﹤0.01%
186,184
-15,377
-8% -$69.9K
EUFN icon
3211
iShares MSCI Europe Financials ETF
EUFN
$4.27B
$862K ﹤0.01%
34,870
-1,566
-4% -$36.7K
GBDC icon
3212
Golub Capital BDC
GBDC
$3.44B
$860K ﹤0.01%
56,949
-2,922
-5% -$44.1K
BSY icon
3213
Bentley Systems
BSY
$10.9B
$855K ﹤0.01%
16,832
-380
-2% -$18.7K
EBND icon
3214
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.27B
$853K ﹤0.01%
40,191
-1,468
-4% -$30.2K
NIC icon
3215
Nicolet Bankshares
NIC
$3.64B
$848K ﹤0.01%
8,872
-170
-2% -$15.9K
JRI icon
3216
Nuveen Real Asset Income & Growth Fund
JRI
$352M
$848K ﹤0.01%
41,994
-23,423
-36% -$300K
MOFG
3217
DELISTED
MidWestOne Financial Group
MOFG
$847K ﹤0.01%
29,700
+13,600
+84% +$369K
DIAX
3218
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
$845K ﹤0.01%
56,959
-11,967
-17% -$172K
JILL icon
3219
J. Jill
JILL
$277M
$842K ﹤0.01%
34,126
EEMS icon
3220
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$368M
$837K ﹤0.01%
13,128
+1,885
+17% +$116K
PGY icon
3221
Pagaya Technologies
PGY
$1.83B
$835K ﹤0.01%
+78,964
New +$1.04M
LVHD icon
3222
Franklin US Low Volatility High Dividend Index ETF
LVHD
$632M
$832K ﹤0.01%
20,443
+1,271
+7% +$49.1K
CACC icon
3223
Credit Acceptance
CACC
$5.99B
$831K ﹤0.01%
1,873
-56
-3% -$27.5K
ARQT icon
3224
Arcutis Biotherapeutics
ARQT
$3.24B
$830K ﹤0.01%
89,267
+11,861
+15% +$117K
SRTA
3225
Strata Critical Medical Inc
SRTA
$482M
$827K ﹤0.01%
+281,362
New +$896K

Similar funds

Ameriprise's Q3 2024 Portfolio in Review

As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
  • Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
  • Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
  • Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
  • Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
  • Ameriprise opened 197 new positions and closed 141 in Q3 2024.
  • Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.

Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.